IKIwona Kucharewicz

Iwona Kucharewicz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Iwona Kucharewicz has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The concentration of kynurenine in rat model of asthma.

    by Iwona Kucharewicz, Irena Kasacka, Dariusz Pawlak, Anna Tankiewicz-Kwedlo, Barbara Mroczko, Wlodzimierz Buczko, Anna Bodzenta-Lukaszyk

    The concentration of kynurenine in rat model of asthma.


    • 1 January 2007
      • Vol. 17  (2) , 65-9

    Basal serum tryptase level correlates with severity of hymenoptera sting and age.

    by I Kucharewicz, A Bodzenta-Lukaszyk, W Szymanski, B Mroczko, M Szmitkowski

    Increased serum tryptase has been linked to the severity of the reaction after Hymenoptera stings. The aim of the study was to measure basal tryptase levels in patients with Hymenoptera venom allergy and investigate the possible correlation between these levels and the severity of sting reaction. One hundred nine patients were included in the study. Sixty-three were wasp venom-allergic and 46 were honey bee venom-allergic. Basal serum tryptase levels were measured by UniCAP. Basal serum tryptase levels were elevated in 12 (11%) of the 109 patients. Levels were 5.14 pg/L (3.62-5.84), 5.3 microg/L (2.94-6.54), 5.18 microg/L (3.71-6.25), and 6.98 microg/L (4.78-12.6), for patients with sting reactions of grade I, II, III and IV (as classified by Mueller), respectively. Basal serum tryptase levels correlated significantly with the sting reaction severity (r = 0.2752; P = .004) and with age (r = 0.2906; P = .002). Sting reaction severity also correlated with age (r = 0.3654; P = .001). Basal serum tryptase levels were found to be elevated in 11% of venom allergic patients and correlated significantly with both sting reaction severity and age.


  • The plasmin system in airway remodeling

    by Iwona Kucharewicz, Krzysztof Kowal, Wlodzimierz Buczko, Anna Bodzenta-Łukaszyk


  • Open Access

    The antithrombotic effect of angiotensin-(1—7) closely resembles that of losartan

    by Iwona Kucharewicz, Ewa Chabielska, Dariusz Pawlak, Tomasz Matys, Roland Rólkowski, Wlodzimierz Buczko

    Angiotensin-(1-7) [Ang-(1-7)] is the bioactive peptide which may be responsible for some of the pharmacological effects of losartan. Our previous study has demonstrated the antithrombotic action of losartan in a model of experimental thrombosis. In the present study, we compared the antithrombotic action of losartan and Ang-(1-7). Acute (10 mg/kg, p.o.) and chronic (10 mg/kg, p.o., three weeks) losartan administration to spontaneously hypertensive rats (SHR) induced a decrease in thrombus weight (1.6±0.6 mg and 1.2±0.3 mg respectively vs. control 2.9±0.8 mg; p-6 and 10 —5 M) also reduced adhesion to fibrillar collagen (38.4±0.1% and 33.8±0.8% respectively vs. control 40.0±0.6%; p<0.05, p<0.001). There were no apparent changes in prothrombin time, activated partial thromboplastin time and euglobulin clot lysis time in losartan and Ang-(1-7)-treated groups. We conclude that, like losartan, Ang-(1-7) is able to act as an antithrombotic agent.